Stipple Bio, Inc.

Biotech Cambridge, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Cambridge, MA
Street
238 Main Street
Zip
02142

Offering

Total offering
$100.2M
Amount sold
$65.1M
First sale
Mar 31, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
15

How this filing compares

Ranked #3 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 33.4× the median.

Other Massachusetts filings this week: 4Mission Capital, LLC, ACCAF LTH LLC, CA Select Co-Investments 2024 (Cayman Feeder), LP, CA Select Co-Investments 2024, LP, CA Velocity Fund (Cayman Feeder), LP

Leadership

Jeffrey Landau — Executive Officer (also: Director)

Vineeta Agarwala — Director

Owen Hughes — Director

Greg Verdine — Director

Aaron Ring — Director

Derek DiRocco — Director

Thilo Schroeder — Director

Filing details

Stipple Bio, Inc. filed a Form D with the SEC on April 6, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts